Study Examines Link Between IBD and Psychiatric Disorders

Patients with inflammatory bowel disease (IBD) face a heightened risk of developing psychiatric disorders both before and after their diagnosis, according to a recent Swedish study. The risk began rising approximately 2-3 years prior to IBD diagnosis, reaching its peak right after diagnosis, then gradually declined over the subsequent years, though it remained elevated even after a decade.

This elevated risk was primarily linked to major depressive disorders, anxiety disorders, and substance misuse, while no increase was seen for psychotic disorders, personality disorders, or attention deficit-hyperactivity disorder. IBD patients were also more likely to develop autism spectrum disorders shortly after diagnosis and eating disorders 5 or more years later.

The heightened risks observed before diagnosis may be attributed to subclinical inflammation, gastrointestinal symptoms, and psychological stress experienced during the diagnostic process. Early identification and integration of mental health support into IBD care is crucial to mitigate adverse outcomes, organize treatment, and improve quality of life.

Despite extensive research on anxiety and depression in IBD patients, most studies focus on the post-diagnostic period, leaving the pre-diagnostic phase largely unexplored. The exact relationship between psychiatric morbidity and IBD onset remains uncertain. The study analyzed 48,230 IBD patients and 210,582 matched reference individuals, finding that 8.6% of IBD patients had a psychiatric disorder before diagnosis, compared to 6.8% of the reference group.

After excluding pre-diagnosis psychiatric disorders, 16.5% of IBD patients developed a psychiatric disorder after diagnosis, compared to 12.8% of the reference group. Major depressive disorders, anxiety disorders, and substance misuse were the most common psychiatric conditions.